(The Ravelcare Ltd Share Price will be finalized post-allotment, while grey market cues through the Ravelcare Ltd IPO GMP will likely show a gain of 40% above the listing price.)

Now, let’s move to what’s working for the company and what’s not before moving onto their history and numbers.

Now let’s move forward to unpacking the whole business story and their numbers - 

The hair‑care brand Ravelcare Limited plans to go public on BSE’s SME platform. Founded by first‑generation entrepreneur Ayush Mahesh Varma and family members, Ravelcare operates in the beauty and personal care (BPC) industry. Its digital‑first direct‑to‑consumer model sells haircare, skincare, bodycare and scalp‑care products through its own website and via major e‑commerce and quick‑commerce platforms such as Amazon, Flipkart, Myntra and Blinkit. The company emphasises data‑driven product development, resulting in high repeat‑order rates that increased from 16.81% in FY2022‑23 to 36.86% in the half‑year ended 30 September 2025.

Ravelcare formulates and sells hair‑care oils (its primary product), shampoos, serums and allied personal‑care products. It positions itself as a digital‑first, direct‑to‑consumer brand and does not currently manufacture products in‑house; instead, it outsources production to a third‑party contract manufacturer. To strengthen its supply chain, the company plans to set up a new manufacturing facility in Mauje‑Peth, Amravati, Maharashtra using IPO proceeds.

Operating segments

Although it sells 13 products across four categories, Ravelcare’s revenue is overwhelmingly driven by haircare. In FY2024‑25 haircare contributed 95.20% of revenue, with skincare, bodycare and scalp‑care contributing only 2.26 %, 1.76 % and 0.78 %, respectively. The company launched its skincare segment in FY2023‑24 and scalp‑care segment in FY2024‑25.

Core products/services:-

Haircare: Anti‑dandruff hair oil, hair growth oil and related products; accounts for >93 % of revenue.

Skincare: Limited range launched in FY2023‑24 including face washes and serums.

Bodycare: Body lotions and soaps.

Scalp‑care: Products launched in FY2024‑25.

Business model in simple terms

Ravelcare operates a digital‑first direct‑to‑consumer model. It develops products based on customer data and sells them primarily through its own website and through major e‑commerce and quick‑commerce platforms. The company currently outsources manufacturing to a third‑party and plans to build its own facility. Marketing relies heavily on digital media and influencer collaborations, which makes sales dependent on e‑commerce algorithms and platform policies.

Revenue Breakdown: Where the Money Comes From?

Segmentation by Product

 Promoters and their stakes 

Collectively, promoters and the promoter group hold 50,02,998 shares, representing 99.96 % of the pre‑issue capital. Post‑issue shareholding will decline following the fresh issue but remains undisclosed in the DRHP.

Key management team

Ravelcare is still tightly controlled by its founding family—before the IPO the promoters together own about 99.96 % of the company’s shares. The driving force is Managing Director Ayush Mahesh Varma, a first‑generation entrepreneur who built the brand’s digital‑first model but openly acknowledges his lack of manufacturing experience. He sets product strategy and oversees marketing, and the planned move into an owned manufacturing facility will test his ability to translate a data‑driven, online operation into a more asset‑intensive business.

His father, Maheshkumar Ramchandra Varma, serves as a whole‑time director and helps run day‑to‑day operations. The finance function is headed by Sagar Doshi, the chief financial officer, who handles budgeting, accounting and compliance. Bhuvnesh Kumar joins them on the board as a whole‑time director; though not a promoter, he provides operational support. To bolster governance, Ravelcare has appointed two independent directors—Ajinkya Rajendra Jain and Shruti Rajesh Sohane—along with company secretary Esha Srivastava. This mix of family leadership and independent oversight gives investors a clearer view into strategy and finance as the firm transitions to public ownership.

No major governance issues are highlighted, although the company notes instances of delayed filing of taxes (TDS/GST) and reliance on family members for management.

Ravelcare’s numbers tell the story of a young brand hitting its stride. Revenue has surged from just ₹3.49 crore in FY 2022‑23 to nearly ₹25 crore in FY 2024‑25, and profits have followed suit, lifting margins from the low teens to around 30 %. The company is clearly getting better at converting top‑line growth into earnings. 

Revenue from operations rose from ₹349.36 lakh in FY 2022‑23 to ₹2,208.78 lakh in FY 2023‑24 and ₹2,497.89 lakh in FY 2024‑25, with the first half of FY 2025 already contributing ₹1,439.76 lakh. EBITDA climbed from about ₹50.95 lakh in FY 2022‑23 to ₹664.1 lakh in FY 2023‑24 and ₹681.9 lakh in FY 2024‑25, while the EBITDA margin improved from roughly 14 % to around 27–30 %. Profit after tax increased from ₹41.53 lakh to ₹502.41 lakh and then to ₹524.76 lakh over the same period, with PAT margins holding above 20 %. Return on equity (ROE) was negative in FY 2022‑23 but turned strongly positive in subsequent years, reflecting the low capital base and expanding profits. The company also reports operating metrics such as website visitors, marketing‑efficiency rate and return on ad spend, which show a sharp rise in digital traffic and improved marketing effectiveness year‑over‑year. The flip side is that rapid scaling strained working capital last year, pushing operating cash flow into the red—a reminder that efficient cash management will be just as important as headline sales growth.

Comparison with Competitors

The DRHP states that there are no listed companies in India that are engaged in the business segment in which they operate or of a comparable size to that of their Company. But there are few pure D2C startups which all operate in the broader Indian hair-/skin-care / personal-care / D2C segment — though what they emphasize and how they operate can differ. They are Traya, Skinkraft and Vedix. Traya and Vedix lean more toward hair-loss / hair-health / therapeutic / Ayurvedic / customised solutions; SkinKraft offers beauty / general hair & skin-care, closer to broad personal-care. Ravelcare might sit somewhere in between (hair & personal care) depending on its exact product mix and positioning. Traya operating revenue in FY 2024 was ~ ₹ 236 crore and in FY23 , it was ~ ₹ 61 crore.

They were loss making in FY2023 with around ₹ 27.83 cr and turned profitable in FY2024 with around ₹ 8.66 cr.  Skinkraft revenue in FY2024 was ~ ₹ 71.5 crore and Vedix revenue in FY2024  was approx ₹ 185–190 crore. These numbers can be used to estimate the market potential and are not direct competitors of Ravelcare.

IPO Objective

• Marketing & advertisement: ₹1,150 lakh to enhance brand awareness.

• Setting up a new manufacturing facility: ₹780.60 lakh to establish a plant in Mauje‑Peth, Amravati.

• General corporate purposes: Cap limited to 15 % of gross proceeds or ₹1,000 lakh, whichever is lower.

The company notes that funding estimates haven’t been appraised by an independent agency.

Here’s what we saw through our LMVT Framework: 

Leadership: Ravelcare is very much a family‑run enterprise. Managing director Ayush Mahesh Varma, who owns the vast majority of the company along with his parents.The appointment of CFO Sagar Doshi and two independent directors adds a measure of professional oversight, but day‑to‑day control remains in promoter hands.  

Moat: The company’s competitive edge is thin. It sells largely commoditised hair‑care products outsourced to a single contract manufacturer and relies heavily on online marketplaces and digital marketing. More than 93 % of revenue comes from hair‑care oils, and its trademark is still under objection. Without proprietary products, manufacturing assets or a registered brand, Ravelcare’s differentiation rests mainly on marketing spend.

Valuation: The pricing looks accessible, It has shown explosive revenue growth in two years and healthy EBITDA margins and it is virtually debt‑free and asset‑light. However, working‑capital needs pushed operating cash flow negative in FY 2024‑25, and future profitability will depend on whether it can control marketing spend and successfully build its own plant.

Tailwinds: The beauty and personal‑care market is growing at 10–11 % annually and shifting rapidly online, trends that favour digital‑first brands like Ravelcare. E‑commerce and quick‑commerce platforms are expanding 39 % year‑on‑year, and younger consumers are increasingly buying beauty products online. These tailwinds could keep demand strong if the company can maintain visibility on crowded platforms with new age D2C companies growing in this sector at a rapid rate.

Bottom line: Ravelcare scores well on growth and margins but less so on defensible advantages. A founder‑driven culture and asset‑light model make for agility, yet the absence of proprietary products, reliance on a single manufacturer and untested in‑house manufacturing plan leave execution risk high. For investors comfortable betting on India’s D2C beauty boom and early‑stage brands, the IPO offers exposure to a fast‑growing niche.

Conservative investors may prefer to watch how repeat purchases, cash flows and brand strength evolve once the marketing spend tapers.